Home / TXMD : NASDAQ

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does TXMD make money? Does TXMD have pricing power? What's the Earnings Whisper? Will TXMD profit more as the business scales? What is TXMD's management track record? Is TXMD's current price justified?

TherapeuticsMD, Inc.

$2.16 +$0.51 (+30.91%)

NASDAQ · 15 Sep 2026 17:39 UTC

Previous Close

$2.16

Day Range

$2.16$2.18

Year Range

$0.99$2.95

Market Cap

25M

AVG Volume

36.25K

Trailing/Forward PE

-115.16/11.37

PEG ratio

-9.79

Dividend Yield

Next Earnings Date

2026-11-17

Primary Exchange

NASDAQ

Revenue (USD) · TTM

TXMD Revenue (USD) · TTM by quarter
Period	Revenue (USD) · TTM
26 Q2	3.27M
26 Q1	3.35M
25 Q4	3.02M
25 Q3	2.8M
25 Q2	2.56M
25 Q1	1.84M
24 Q4	1.76M
24 Q3	1.6M
24 Q2	996K
24 Q1	1.2M

Net Income (USD) · TTM

TXMD Net Income (USD) · TTM by quarter
Period	Net Income (USD) · TTM
26 Q2	-217K
26 Q1	179K
25 Q4	-569K
25 Q3	302K
25 Q2	-459K
25 Q1	-2.1M
24 Q4	-2.18M
24 Q3	-3.32M
24 Q2	-6.08M
24 Q1	-7.41M

Operating Income (USD) · TTM

TXMD Operating Income (USD) · TTM by quarter
Period	Operating Income (USD) · TTM
26 Q2	-3.85M
26 Q1	-3.74M
25 Q4	-4.21M
25 Q3	-3.04M
25 Q2	-3.07M
25 Q1	-5.16M
24 Q4	-5.11M
24 Q3	-6.4M
24 Q2	-7.32M
24 Q1	-7M

EBITDA (USD) · TTM

TXMD EBITDA (USD) · TTM by quarter
Period	EBITDA (USD) · TTM
26 Q2	-4.2M
26 Q1	-3.08M
25 Q4	-3.55M
25 Q3	-518K
25 Q2	-1.43M
25 Q1	-3.07M
24 Q4	-2.98M
24 Q3	-3.63M
24 Q2	-4.15M
24 Q1	-5.39M

Cash Flows (USD) · TTM

TXMD Cash Flows (USD) · TTM by quarter
Period	Cash Flows (USD) · TTM
26 Q2	3.12M
26 Q1	2.67M
25 Q4	2.42M
25 Q3	2.07M
25 Q2	837K
25 Q1	1.41M
24 Q4	732K
24 Q3	720K
24 Q2	-1.55M
24 Q1	-7.11M

EPS (USD) · TTM

TXMD EPS (USD) · TTM by quarter
Period	EPS (USD) · TTM
26 Q2	-0.02
26 Q1	0.02
25 Q4	-0.05
25 Q3	0.03
25 Q2	-0.04
25 Q1	-0.18
24 Q4	-0.19
24 Q3	-0.29
24 Q2	-0.55
24 Q1	-0.7

Expenses (USD) · TTM

TXMD Expenses (USD) · TTM by quarter
Period	Expenses (USD) · TTM
26 Q2	6.74M
26 Q1	6.71M
25 Q4	6.85M
25 Q3	5.44M
25 Q2	5.51M
25 Q1	5.54M
24 Q4	5.37M
24 Q3	-1.88M
24 Q2	-1.87M
24 Q1	-672K

Shares Outstanding · TTM

TXMD Shares Outstanding · TTM by quarter
Period	Shares Outstanding · TTM
26 Q2	0
26 Q1	0
25 Q4	0
25 Q3	-24K
25 Q2	-24K
25 Q1	-120K
24 Q4	-120K
24 Q3	-96K
24 Q2	-96K
24 Q1	0

Employee Count

TXMD Employee Count by quarter
Period	Employee Count
2025	1
2024	1
2023	1
2022	1
2021	416
2020	400
2019	348
2018	241
2017	173
2016	159

PE Ratio

TXMD PE Ratio by quarter
Period	PE Ratio
Aug 26	133.84
Jul 26	131.26
Jul 26	133.2
Jul 26	133.2
Jul 26	129.32
Jul 26	136.43
Jun 26	136.43
Jun 26	126.09
Jun 26	142.25
Jun 26	128.67
May 26	138.37
May 26	137.08
May 26	129.32
Mar 26	80.48
Mar 26	85.85
Mar 26	83.16
Mar 26	86.23
Feb 26	86.61
Feb 26	88.15
Feb 26	90.45
Feb 26	87.76
Jan 26	82.78
Jan 26	100.03
Jan 26	85.46
Jan 26	82.78
Jan 26	63.24
Dec 25	66.68
Dec 25	65.15
Dec 25	67.07
Dec 25	66.68
Nov 25	65.15
Nov 25	68.22
Nov 25	75.12
Aug 23	0.83
Aug 23	0.89
Jul 23	0.84
Jul 23	0.88
Jul 23	0.82
Jul 23	0.85
Jun 23	0.86
Jun 23	0.85
Jun 23	0.81
Jun 23	0.85
Jun 23	0.92
May 23	0.81
May 23	0.91

Free Cash Flow Yield

TXMD Free Cash Flow Yield by quarter
Period	Free Cash Flow Yield
Sep 26	12.48%
Sep 26	12.48%
Sep 26	12.2%
Aug 26	12.14%
Aug 26	13.09%
Aug 26	13.02%
Aug 26	11.16%
Jul 26	11.38%
Jul 26	11.22%
Jul 26	11.22%
Jul 26	11.55%
Jul 26	10.95%
Jun 26	10.95%
Jun 26	11.85%
Jun 26	10.5%
Jun 26	11.61%
May 26	10.8%
May 26	10.9%
May 26	11.55%
May 26	10.58%
May 26	10.12%
Apr 26	9.57%
Apr 26	10.12%
Apr 26	10.12%
Apr 26	10.48%
Mar 26	8.51%
Mar 26	7.98%
Mar 26	8.23%
Mar 26	7.94%
Feb 26	7.91%
Feb 26	7.77%
Feb 26	7.57%
Feb 26	7.8%
Jan 26	8.27%
Jan 26	6.85%
Jan 26	8.01%
Jan 26	8.27%
Jan 26	10.83%
Dec 25	10.27%
Dec 25	10.51%
Dec 25	10.21%
Dec 25	10.27%
Nov 25	10.51%
Nov 25	10.04%
Nov 25	9.12%
Nov 25	5.2%
Oct 25	6.08%
Oct 25	5.61%
Oct 25	5.79%
Oct 25	6.95%
Oct 25	6.76%
Sep 25	6.76%
Sep 25	6.63%
Sep 25	6.52%
Sep 25	6.7%
Aug 25	6.52%
Aug 25	6.57%
Aug 25	6.18%
Aug 25	11.49%
Aug 25	10.97%
Jul 25	10.24%
Jul 25	10.59%
Jul 25	10.32%
Jul 25	10.32%
Jun 25	10.87%
Jun 25	11.17%
Jun 25	10.41%
Jun 25	9.74%
May 25	8.34%
May 25	8.4%
May 25	8.12%
May 25	4.35%
May 25	4.47%
Apr 25	5.43%
Apr 25	6.18%
Apr 25	6.31%
Apr 25	7.06%
Mar 25	6.36%
Mar 25	7.02%
Mar 25	8.61%
Mar 25	7.18%
Feb 25	6.71%
Feb 25	4.8%
Feb 25	6.06%
Feb 25	6.12%
Jan 25	5.78%
Jan 25	5.43%
Jan 25	5.89%
Jan 25	5.68%
Jan 25	4.25%
Dec 24	5.73%
Dec 24	5.62%
Dec 24	5.12%
Dec 24	5.08%
Nov 24	4.4%
Nov 24	4.56%
Nov 24	4.46%
Nov 24	-8.84%
Nov 24	-8.67%
Oct 24	-8.45%

Price to Sales

TXMD Price to Sales by quarter
Period	Price to Sales
Sep 26	7.65
Sep 26	7.65
Sep 26	7.82
Aug 26	7.86
Aug 26	7.29
Aug 26	7.33
Aug 26	7.15
Jul 26	7.01
Jul 26	7.11
Jul 26	7.11
Jul 26	6.9
Jul 26	7.28
Jun 26	7.28
Jun 26	6.73
Jun 26	7.59
Jun 26	6.87
May 26	7.39
May 26	7.32
May 26	6.9
May 26	7.58
May 26	7.92
Apr 26	8.38
Apr 26	7.92
Apr 26	7.92
Apr 26	7.66
Mar 26	8.69
Mar 26	9.27
Mar 26	8.98
Mar 26	9.31
Feb 26	9.36
Feb 26	9.52
Feb 26	9.77
Feb 26	9.48
Jan 26	8.94
Jan 26	10.8
Jan 26	9.23
Jan 26	8.94
Jan 26	6.83
Dec 25	7.2
Dec 25	7.04
Dec 25	7.24
Dec 25	7.2
Nov 25	7.04
Nov 25	7.37
Nov 25	8.11
Nov 25	6.29
Oct 25	5.38
Oct 25	5.83
Oct 25	5.65
Oct 25	4.7
Oct 25	4.84
Sep 25	4.84
Sep 25	4.93
Sep 25	5.02
Sep 25	4.88
Aug 25	5.02
Aug 25	4.98
Aug 25	5.29
Aug 25	6.65
Aug 25	6.97
Jul 25	7.47
Jul 25	7.22
Jul 25	7.4
Jul 25	7.4
Jun 25	7.03
Jun 25	6.84
Jun 25	7.34
Jun 25	7.84
May 25	9.16
May 25	9.1
May 25	9.41
May 25	9.56
May 25	9.3
Apr 25	8.31
Apr 25	7.3
Apr 25	7.15
Apr 25	6.39
Mar 25	7.1
Mar 25	6.43
Mar 25	5.24
Mar 25	6.29
Feb 25	6.72
Feb 25	9.39
Feb 25	7.44
Feb 25	7.37
Jan 25	7.8
Jan 25	8.31
Jan 25	7.66
Jan 25	7.95
Jan 25	10.62
Dec 24	7.88
Dec 24	8.02
Dec 24	8.82
Dec 24	8.89
Nov 24	10.26
Nov 24	9.9
Nov 24	10.12
Nov 24	17.6
Nov 24	17.95
Oct 24	18.41

EV/EBITDA

TXMD EV/EBITDA by quarter
Period	EV/EBITDA
Apr 24	0.17
Apr 24	0.17
Apr 24	0.19
Apr 24	0.21
Mar 24	0.22
Mar 24	0.22
Mar 24	0.23
Mar 24	0.22
Mar 24	0.24
Feb 24	0.21
Feb 24	0.21
Feb 24	0.22
Feb 24	0.22
Jan 24	0.22
Jan 24	0.21
Jan 24	0.22
Jan 24	0.22
Dec 23	0.21
Dec 23	0.22
Dec 23	0.22
Dec 23	0.2
Dec 23	0.26
Nov 23	0.29
Nov 23	0.21
Nov 23	0.18
Nov 23	0.2
Oct 23	0.18
Oct 23	0.21
Oct 23	0.24
Oct 23	0.28
Sep 23	0.3
Sep 23	0.3
Sep 23	0.34
Sep 23	0.37
Sep 23	0.39
Aug 23	0.42
Aug 23	0.39
Aug 23	0.41
Aug 23	0.45
Jul 23	0.41
Jul 23	0.44
Jul 23	0.4
Jul 23	0.42
Jun 23	0.43
Jun 23	0.42
Jun 23	0.39
Jun 23	0.42
Jun 23	0.47
May 23	0.39
May 23	0.45
May 23	0.2
May 23	0.11
Apr 23	0.07
Apr 23	0.1
Apr 23	0.08

Price/Operating Cashflow

TXMD Price/Operating Cashflow by quarter
Period	Price/Operating Cashflow
Sep 26	8.01
Sep 26	8.01
Sep 26	8.2
Aug 26	8.24
Aug 26	7.64
Aug 26	7.68
Aug 26	8.96
Jul 26	8.79
Jul 26	8.92
Jul 26	8.92
Jul 26	8.66
Jul 26	9.13
Jun 26	9.13
Jun 26	8.44
Jun 26	9.52
Jun 26	8.61
May 26	9.26
May 26	9.18
May 26	8.66
May 26	9.45
May 26	9.88
Apr 26	10.45
Apr 26	9.88
Apr 26	9.88
Apr 26	9.55
Mar 26	11.75
Mar 26	12.54
Mar 26	12.14
Mar 26	12.59
Feb 26	12.65
Feb 26	12.87
Feb 26	13.21
Feb 26	12.82
Jan 26	12.09
Jan 26	14.61
Jan 26	12.48
Jan 26	12.09
Jan 26	9.23
Dec 25	9.74
Dec 25	9.51
Dec 25	9.79
Dec 25	9.74
Nov 25	9.51
Nov 25	9.96
Nov 25	10.97
Nov 25	19.22
Oct 25	16.46
Oct 25	17.84
Oct 25	17.28
Oct 25	14.38
Oct 25	14.8
Sep 25	14.8
Sep 25	15.07
Sep 25	15.35
Sep 25	14.93
Aug 25	15.35
Aug 25	15.21
Aug 25	16.18
Aug 25	8.7
Aug 25	9.11
Jul 25	9.77
Jul 25	9.44
Jul 25	9.69
Jul 25	9.69
Jun 25	9.2
Jun 25	8.95
Jun 25	9.61
Jun 25	10.26
May 25	11.99
May 25	11.91
May 25	12.32
May 25	23
May 25	22.37
Apr 24	1.02
Apr 24	1.02
Apr 24	1.09
Apr 24	1.21
Mar 24	1.26
Mar 24	1.26
Mar 24	1.32
Mar 24	1.28
Mar 24	1.4
Feb 24	1.24
Feb 24	1.24
Feb 24	1.26
Feb 24	1.25
Jan 24	1.25
Jan 24	1.23
Jan 24	1.25
Jan 24	1.25
Dec 23	1.24
Dec 23	1.27
Dec 23	1.29
Dec 23	1.14
Dec 23	1.51
Nov 23	0.94
Nov 23	0.72
Nov 23	0.63
Nov 23	0.7
Oct 23	0.64

Price to Book

TXMD Price to Book by quarter
Period	Price to Book
Sep 26	0.92
Sep 26	0.92
Sep 26	0.94
Aug 26	0.95
Aug 26	0.88
Aug 26	0.88
Aug 26	0.89
Jul 26	0.87
Jul 26	0.88
Jul 26	0.88
Jul 26	0.86
Jul 26	0.91
Jun 26	0.91
Jun 26	0.84
Jun 26	0.94
Jun 26	0.85
May 26	0.92
May 26	0.91
May 26	0.86
May 26	0.85
May 26	0.89
Apr 26	0.94
Apr 26	0.89
Apr 26	0.89
Apr 26	0.86
Mar 26	0.89
Mar 26	0.94
Mar 26	0.92
Mar 26	0.95
Feb 26	0.95
Feb 26	0.97
Feb 26	1
Feb 26	0.97
Jan 26	0.91
Jan 26	1.1
Jan 26	0.94
Jan 26	0.91
Jan 26	0.7
Dec 25	0.73
Dec 25	0.72
Dec 25	0.74
Dec 25	0.73
Nov 25	0.72
Nov 25	0.75
Nov 25	0.83
Nov 25	0.59
Oct 25	0.5
Oct 25	0.55
Oct 25	0.53
Oct 25	0.44
Oct 25	0.45
Sep 25	0.45
Sep 25	0.46
Sep 25	0.47
Sep 25	0.46
Aug 25	0.47
Aug 25	0.47
Aug 25	0.5
Aug 25	0.46
Aug 25	0.48
Jul 25	0.51
Jul 25	0.5
Jul 25	0.51
Jul 25	0.51
Jun 25	0.48
Jun 25	0.47
Jun 25	0.51
Jun 25	0.54
May 25	0.63
May 25	0.63
May 25	0.65
May 25	0.62
May 25	0.6
Apr 25	0.49
Apr 25	0.43
Apr 25	0.42
Apr 25	0.38
Mar 25	0.42
Mar 25	0.38
Mar 25	0.31
Mar 25	0.37
Feb 25	0.4
Feb 25	0.55
Feb 25	0.44
Feb 25	0.43
Jan 25	0.46
Jan 25	0.49
Jan 25	0.45
Jan 25	0.47
Jan 25	0.63
Dec 24	0.46
Dec 24	0.47
Dec 24	0.52
Dec 24	0.52
Nov 24	0.6
Nov 24	0.58
Nov 24	0.6
Nov 24	0.63
Nov 24	0.65
Oct 24	0.66

No video analysis for this stock yet. Request one from our team.

News: TXMD

gurufocus.com · 11 Aug 2026

TherapeuticsMD Announces Second Quarter 2026 Financial Results

TherapeuticsMD, Inc. (âTherapeuticsMDâ or the âCompanyâ) (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financia

businesswire.com · 11 Aug 2026

TherapeuticsMD Announces Second Quarter 2026 Financial Results

BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (“TherapeuticsMD” or the “Company”) (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results for the three months ended June 30, 2026. Second Quarter 2026 Financial Results Net Income from Continuing Operations Net income from continuing operations totaled $164 thousand, compared to net income of $545 thousand for the second quarter of 2025. License Revenues from Continuing Operations The Com.

AI Analysis

TherapeuticsMD, Inc.

Video analysis: TXMD

News: TXMD

TherapeuticsMD Announces Second Quarter 2026 Financial Results

TherapeuticsMD Announces Second Quarter 2026 Financial Results

Similar companies